Reversible Hepatotoxicity of Mirtazapine in a Patient with Major Depression
Yükleniyor...
Dosyalar
Tarih
2011
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Galenos Yayincilik
Erişim Hakkı
info:eu-repo/semantics/closedAccess
Özet
Mirtazapine is a noradrenergic and specific serotonergic antidepressant that is approved for use in the treatment of major depression. It is generally well tolerated with some mild side effects such as drowsiness, excessive sedation, increased appetite, weight gain, and dry mouth. We present a case of 23 years old female depressive patient who developed abdominal pain and elevation of liver enzymes during treatment with mirtazapine and returned to normal after stopping the mirtazapine use. (Archives of Neuropsychiatry 2011; 48: 162-3)
Açıklama
WOS: 000292729200014
Anahtar Kelimeler
Hepatotoxicity, major depression, mirtazapine
Kaynak
Noropsikiyatri Arsivi-Archives Of Neuropsychiatry
WoS Q Değeri
Q4
Scopus Q Değeri
Cilt
48
Sayı
2
